Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon

Bilal Abou Ali, Ralph Nader, Hani Tamim, Toufic Eid, Fouad Boulos, Nabil Khoury, Samir Akel, Rachid Haidar, Said Saghieh, Miguel Abboud, Samar Muwakkit, Hassan El-Solh, Raya Saab

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Treatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries.

Original languageEnglish
Pages (from-to)1472-1475
Number of pages4
JournalPediatric Blood and Cancer
Issue number8
StatePublished - Aug 2014


  • Ewing sarcoma
  • Pediatric
  • Prognostic factors


Dive into the research topics of 'Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon'. Together they form a unique fingerprint.

Cite this